SCHEMBL28906185

SCHEMBL28906185

CCCC[Sn](CCCC)(CCCC)c1nnn(C[Si](C)(C)C)c1C(=O)OC

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30
PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4291234 0.80 SMN1; SMN2 (0.51)
SCHEMBL14736717 0.73 LMNA (0.49) LMNAPTGES
SCHEMBL14736718 0.68 NPC1 (0.50) LMNAPTGES
SCHEMBL28937924 0.66
SCHEMBL25045436 0.64 LMNA (0.45) LMNA
SCHEMBL25045051 0.62 PTGER4 (0.37) LMNAPTGES
SCHEMBL1590278 0.61
SCHEMBL1412412 0.60 NPC1 (0.47) LMNAPTGES
SCHEMBL21228674 0.60 NPC1 (0.56) LMNAPTGES
SCHEMBL6570768 0.58 KDM4E (0.44) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149933-A1 NEW TRIAZOLYL DERIVATIVES AS GABA A ALPHA5 PAM F. Hoffmann-La Roche AG (CH) 2023-03-22 EP disclosed
CN-115461337-A Novel triazolyl derivatives as GABA A alpha 5 PAM 豪夫迈·罗氏有限公司 2022-12-09 CN disclosed